Home » International Drug Policy: Looking Forward to Enhanced Safety in 2013
International Drug Policy: Looking Forward to Enhanced Safety in 2013
January 10, 2013
New pharmacovigilance and clinical trial regulations in the EU, stronger protections on active pharmaceutical ingredients in numerous countries, changes in national patent systems and a push for more supply chain safety to protect against falsified drugs all generated headlines in 2012, and IPRM was there to bring readers the latest details and insider perspective. Use this recap of the past year’s major regulatory events to ensure success in the year ahead.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor